Skip to main content
Premium Trial:

Request an Annual Quote

Authoring After the Fact

Elsevier is doing its own investigation into whether an "Editor's Choice" article appearing in the May 2003 issue of the American Journal of Obstetrics and Gynecology was "improperly ghostwritten by a drug company promoting the product," the New York Times reports. This inquiry follows on the heels of Senator Charles Grassley (R-Iowa) saying that Wyeth commissioned the article and it was written by DesignWrite, and only after that was a physician, John Eden of the University of New South Wales, found to author the article.

The article under investigation addressed the Women's Health Initiative, which ended early when women taking Wyeth's Prempro were found to have a higher risk of developing breast cancer and  it said "any association of progesterone with breast cancer risk remains controversial."

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.